Alzheimer's disease : Correlation of the suppression of β-amyloid Peptide secretion from cultured cells with inhibition of the chymotrypsin-like activity of the proteasome

Peptide aldehyde inhibitors of the chymotrypsin-like activity of the proteasome (CLIP) such as N-acetyl-Leu-Leu-Nle-H (or ALLN) have been shown previously to inhibit the secretion of beta-amyloid peptide (A beta) from cells. To evaluate more fully the role of the proteasome in this process, we have...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of neurochemistry 1999-07, Vol.73 (1), p.195-204
Hauptverfasser: CHRISTIE, G, MARKWELL, R. E, WARD, R. V, HOWLETT, D. R, HARTMANN, T, LICHTENTHALER, S. F, BEYREUTHER, K, UNDERWOOD, J, GRIBBLE, S. K, CAPPAI, R, MASTERS, C. L, TAMAOKA, A, GRAY, C. W, GARDNER, R. L, RIVETT, A. J, KARRAN, E. H, ALLSOP, D, SMITH, L, GODFREY, F, MANSFIELD, F, WADSWORTH, H, KING, R, MCLAUGHLIN, M, COOPER, D. G
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 204
container_issue 1
container_start_page 195
container_title Journal of neurochemistry
container_volume 73
creator CHRISTIE, G
MARKWELL, R. E
WARD, R. V
HOWLETT, D. R
HARTMANN, T
LICHTENTHALER, S. F
BEYREUTHER, K
UNDERWOOD, J
GRIBBLE, S. K
CAPPAI, R
MASTERS, C. L
TAMAOKA, A
GRAY, C. W
GARDNER, R. L
RIVETT, A. J
KARRAN, E. H
ALLSOP, D
SMITH, L
GODFREY, F
MANSFIELD, F
WADSWORTH, H
KING, R
MCLAUGHLIN, M
COOPER, D. G
description Peptide aldehyde inhibitors of the chymotrypsin-like activity of the proteasome (CLIP) such as N-acetyl-Leu-Leu-Nle-H (or ALLN) have been shown previously to inhibit the secretion of beta-amyloid peptide (A beta) from cells. To evaluate more fully the role of the proteasome in this process, we have tested the effects on A beta formation of a much wider range of peptide-based inhibitors of CLIP than published previously. The inhibitors tested included several peptide boronates, some of which proved to be the most potent peptide-based inhibitors of beta-amyloid production reported so far. We found that the ability of the peptide aldehyde and boronate inhibitors to suppress A beta formation from cells correlated extremely well with their potency as CLIP inhibitors. Thus, we conclude that the proteasome may be involved either directly or indirectly in A beta formation.
doi_str_mv 10.1046/j.1471-4159.1999.0730195.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69853980</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69853980</sourcerecordid><originalsourceid>FETCH-LOGICAL-c318t-9558e7b3201b93c90c6e3f2fb6f4078f2c86ddf68317671f5994aadb39bf4f883</originalsourceid><addsrcrecordid>eNqFkcFu1DAQhi0EokvhFZCFEJwS7Dhx7N6qFQWkSnCAs-U4Y8VLsg62Aw3PxKkPwjORsAF64zSS5_tnxvoQekZJTknJXx1yWtY0K2klcyqlzEnNCJVVfnMP7f627qMdIUWRMVIWZ-hRjAdCKC85fYjOKGGCy5ru0I_L_nsHboDwMuLWRdAR8AXe-xCg18n5I_YWpw5wnMYxQIzb08_bTA9z712LP8CYXLsQYAL8jtjgB2ymPk0BWmyg7yP-5lKH3bFzjbs71nTz4FOYx-iOWe8-A9Ymua8uzX-IMfi0nOUHeIweWN1HeLLVc_Tp6vXH_dvs-v2bd_vL68wwKlImq0pA3bCC0EYyI4nhwGxhG25LUgtbGMHb1nLBaM1raispS63bhsnGllYIdo5enOYuq79MEJMaXFx_oY_gp6i4FBWTgvwXpHVJqCB0AS9OoAk-xgBWjcENOsyKErVKVQe1mlOrObVKVZtUdbOEn25bpmaA9k70ZHEBnm-Ajkb3NuijcfEfJ0QtGGO_AJHnsA4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17401801</pqid></control><display><type>article</type><title>Alzheimer's disease : Correlation of the suppression of β-amyloid Peptide secretion from cultured cells with inhibition of the chymotrypsin-like activity of the proteasome</title><source>Wiley Free Content</source><source>MEDLINE</source><source>IngentaConnect Free/Open Access Journals</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Free Full-Text Journals in Chemistry</source><creator>CHRISTIE, G ; MARKWELL, R. E ; WARD, R. V ; HOWLETT, D. R ; HARTMANN, T ; LICHTENTHALER, S. F ; BEYREUTHER, K ; UNDERWOOD, J ; GRIBBLE, S. K ; CAPPAI, R ; MASTERS, C. L ; TAMAOKA, A ; GRAY, C. W ; GARDNER, R. L ; RIVETT, A. J ; KARRAN, E. H ; ALLSOP, D ; SMITH, L ; GODFREY, F ; MANSFIELD, F ; WADSWORTH, H ; KING, R ; MCLAUGHLIN, M ; COOPER, D. G</creator><creatorcontrib>CHRISTIE, G ; MARKWELL, R. E ; WARD, R. V ; HOWLETT, D. R ; HARTMANN, T ; LICHTENTHALER, S. F ; BEYREUTHER, K ; UNDERWOOD, J ; GRIBBLE, S. K ; CAPPAI, R ; MASTERS, C. L ; TAMAOKA, A ; GRAY, C. W ; GARDNER, R. L ; RIVETT, A. J ; KARRAN, E. H ; ALLSOP, D ; SMITH, L ; GODFREY, F ; MANSFIELD, F ; WADSWORTH, H ; KING, R ; MCLAUGHLIN, M ; COOPER, D. G</creatorcontrib><description>Peptide aldehyde inhibitors of the chymotrypsin-like activity of the proteasome (CLIP) such as N-acetyl-Leu-Leu-Nle-H (or ALLN) have been shown previously to inhibit the secretion of beta-amyloid peptide (A beta) from cells. To evaluate more fully the role of the proteasome in this process, we have tested the effects on A beta formation of a much wider range of peptide-based inhibitors of CLIP than published previously. The inhibitors tested included several peptide boronates, some of which proved to be the most potent peptide-based inhibitors of beta-amyloid production reported so far. We found that the ability of the peptide aldehyde and boronate inhibitors to suppress A beta formation from cells correlated extremely well with their potency as CLIP inhibitors. Thus, we conclude that the proteasome may be involved either directly or indirectly in A beta formation.</description><identifier>ISSN: 0022-3042</identifier><identifier>EISSN: 1471-4159</identifier><identifier>DOI: 10.1046/j.1471-4159.1999.0730195.x</identifier><identifier>PMID: 10386971</identifier><identifier>CODEN: JONRA9</identifier><language>eng</language><publisher>Oxford: Blackwell</publisher><subject>Aldehydes - pharmacology ; Alzheimer Disease - metabolism ; Amyloid beta-Peptides - analysis ; Amyloid beta-Peptides - metabolism ; Amyloid beta-Protein Precursor - genetics ; Biological and medical sciences ; Boronic Acids - pharmacology ; Cell Line ; Chymotrypsin - antagonists &amp; inhibitors ; Chymotrypsin - metabolism ; Cysteine Endopeptidases - metabolism ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; Medical sciences ; Multienzyme Complexes - metabolism ; Neurology ; Peptide Fragments - analysis ; Peptide Fragments - metabolism ; Proteasome Endopeptidase Complex ; proteasomes ; Transfection</subject><ispartof>Journal of neurochemistry, 1999-07, Vol.73 (1), p.195-204</ispartof><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c318t-9558e7b3201b93c90c6e3f2fb6f4078f2c86ddf68317671f5994aadb39bf4f883</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1887833$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10386971$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>CHRISTIE, G</creatorcontrib><creatorcontrib>MARKWELL, R. E</creatorcontrib><creatorcontrib>WARD, R. V</creatorcontrib><creatorcontrib>HOWLETT, D. R</creatorcontrib><creatorcontrib>HARTMANN, T</creatorcontrib><creatorcontrib>LICHTENTHALER, S. F</creatorcontrib><creatorcontrib>BEYREUTHER, K</creatorcontrib><creatorcontrib>UNDERWOOD, J</creatorcontrib><creatorcontrib>GRIBBLE, S. K</creatorcontrib><creatorcontrib>CAPPAI, R</creatorcontrib><creatorcontrib>MASTERS, C. L</creatorcontrib><creatorcontrib>TAMAOKA, A</creatorcontrib><creatorcontrib>GRAY, C. W</creatorcontrib><creatorcontrib>GARDNER, R. L</creatorcontrib><creatorcontrib>RIVETT, A. J</creatorcontrib><creatorcontrib>KARRAN, E. H</creatorcontrib><creatorcontrib>ALLSOP, D</creatorcontrib><creatorcontrib>SMITH, L</creatorcontrib><creatorcontrib>GODFREY, F</creatorcontrib><creatorcontrib>MANSFIELD, F</creatorcontrib><creatorcontrib>WADSWORTH, H</creatorcontrib><creatorcontrib>KING, R</creatorcontrib><creatorcontrib>MCLAUGHLIN, M</creatorcontrib><creatorcontrib>COOPER, D. G</creatorcontrib><title>Alzheimer's disease : Correlation of the suppression of β-amyloid Peptide secretion from cultured cells with inhibition of the chymotrypsin-like activity of the proteasome</title><title>Journal of neurochemistry</title><addtitle>J Neurochem</addtitle><description>Peptide aldehyde inhibitors of the chymotrypsin-like activity of the proteasome (CLIP) such as N-acetyl-Leu-Leu-Nle-H (or ALLN) have been shown previously to inhibit the secretion of beta-amyloid peptide (A beta) from cells. To evaluate more fully the role of the proteasome in this process, we have tested the effects on A beta formation of a much wider range of peptide-based inhibitors of CLIP than published previously. The inhibitors tested included several peptide boronates, some of which proved to be the most potent peptide-based inhibitors of beta-amyloid production reported so far. We found that the ability of the peptide aldehyde and boronate inhibitors to suppress A beta formation from cells correlated extremely well with their potency as CLIP inhibitors. Thus, we conclude that the proteasome may be involved either directly or indirectly in A beta formation.</description><subject>Aldehydes - pharmacology</subject><subject>Alzheimer Disease - metabolism</subject><subject>Amyloid beta-Peptides - analysis</subject><subject>Amyloid beta-Peptides - metabolism</subject><subject>Amyloid beta-Protein Precursor - genetics</subject><subject>Biological and medical sciences</subject><subject>Boronic Acids - pharmacology</subject><subject>Cell Line</subject><subject>Chymotrypsin - antagonists &amp; inhibitors</subject><subject>Chymotrypsin - metabolism</subject><subject>Cysteine Endopeptidases - metabolism</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>Medical sciences</subject><subject>Multienzyme Complexes - metabolism</subject><subject>Neurology</subject><subject>Peptide Fragments - analysis</subject><subject>Peptide Fragments - metabolism</subject><subject>Proteasome Endopeptidase Complex</subject><subject>proteasomes</subject><subject>Transfection</subject><issn>0022-3042</issn><issn>1471-4159</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcFu1DAQhi0EokvhFZCFEJwS7Dhx7N6qFQWkSnCAs-U4Y8VLsg62Aw3PxKkPwjORsAF64zSS5_tnxvoQekZJTknJXx1yWtY0K2klcyqlzEnNCJVVfnMP7f627qMdIUWRMVIWZ-hRjAdCKC85fYjOKGGCy5ru0I_L_nsHboDwMuLWRdAR8AXe-xCg18n5I_YWpw5wnMYxQIzb08_bTA9z712LP8CYXLsQYAL8jtjgB2ymPk0BWmyg7yP-5lKH3bFzjbs71nTz4FOYx-iOWe8-A9Ymua8uzX-IMfi0nOUHeIweWN1HeLLVc_Tp6vXH_dvs-v2bd_vL68wwKlImq0pA3bCC0EYyI4nhwGxhG25LUgtbGMHb1nLBaM1raispS63bhsnGllYIdo5enOYuq79MEJMaXFx_oY_gp6i4FBWTgvwXpHVJqCB0AS9OoAk-xgBWjcENOsyKErVKVQe1mlOrObVKVZtUdbOEn25bpmaA9k70ZHEBnm-Ajkb3NuijcfEfJ0QtGGO_AJHnsA4</recordid><startdate>19990701</startdate><enddate>19990701</enddate><creator>CHRISTIE, G</creator><creator>MARKWELL, R. E</creator><creator>WARD, R. V</creator><creator>HOWLETT, D. R</creator><creator>HARTMANN, T</creator><creator>LICHTENTHALER, S. F</creator><creator>BEYREUTHER, K</creator><creator>UNDERWOOD, J</creator><creator>GRIBBLE, S. K</creator><creator>CAPPAI, R</creator><creator>MASTERS, C. L</creator><creator>TAMAOKA, A</creator><creator>GRAY, C. W</creator><creator>GARDNER, R. L</creator><creator>RIVETT, A. J</creator><creator>KARRAN, E. H</creator><creator>ALLSOP, D</creator><creator>SMITH, L</creator><creator>GODFREY, F</creator><creator>MANSFIELD, F</creator><creator>WADSWORTH, H</creator><creator>KING, R</creator><creator>MCLAUGHLIN, M</creator><creator>COOPER, D. G</creator><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>19990701</creationdate><title>Alzheimer's disease : Correlation of the suppression of β-amyloid Peptide secretion from cultured cells with inhibition of the chymotrypsin-like activity of the proteasome</title><author>CHRISTIE, G ; MARKWELL, R. E ; WARD, R. V ; HOWLETT, D. R ; HARTMANN, T ; LICHTENTHALER, S. F ; BEYREUTHER, K ; UNDERWOOD, J ; GRIBBLE, S. K ; CAPPAI, R ; MASTERS, C. L ; TAMAOKA, A ; GRAY, C. W ; GARDNER, R. L ; RIVETT, A. J ; KARRAN, E. H ; ALLSOP, D ; SMITH, L ; GODFREY, F ; MANSFIELD, F ; WADSWORTH, H ; KING, R ; MCLAUGHLIN, M ; COOPER, D. G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c318t-9558e7b3201b93c90c6e3f2fb6f4078f2c86ddf68317671f5994aadb39bf4f883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Aldehydes - pharmacology</topic><topic>Alzheimer Disease - metabolism</topic><topic>Amyloid beta-Peptides - analysis</topic><topic>Amyloid beta-Peptides - metabolism</topic><topic>Amyloid beta-Protein Precursor - genetics</topic><topic>Biological and medical sciences</topic><topic>Boronic Acids - pharmacology</topic><topic>Cell Line</topic><topic>Chymotrypsin - antagonists &amp; inhibitors</topic><topic>Chymotrypsin - metabolism</topic><topic>Cysteine Endopeptidases - metabolism</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>Medical sciences</topic><topic>Multienzyme Complexes - metabolism</topic><topic>Neurology</topic><topic>Peptide Fragments - analysis</topic><topic>Peptide Fragments - metabolism</topic><topic>Proteasome Endopeptidase Complex</topic><topic>proteasomes</topic><topic>Transfection</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>CHRISTIE, G</creatorcontrib><creatorcontrib>MARKWELL, R. E</creatorcontrib><creatorcontrib>WARD, R. V</creatorcontrib><creatorcontrib>HOWLETT, D. R</creatorcontrib><creatorcontrib>HARTMANN, T</creatorcontrib><creatorcontrib>LICHTENTHALER, S. F</creatorcontrib><creatorcontrib>BEYREUTHER, K</creatorcontrib><creatorcontrib>UNDERWOOD, J</creatorcontrib><creatorcontrib>GRIBBLE, S. K</creatorcontrib><creatorcontrib>CAPPAI, R</creatorcontrib><creatorcontrib>MASTERS, C. L</creatorcontrib><creatorcontrib>TAMAOKA, A</creatorcontrib><creatorcontrib>GRAY, C. W</creatorcontrib><creatorcontrib>GARDNER, R. L</creatorcontrib><creatorcontrib>RIVETT, A. J</creatorcontrib><creatorcontrib>KARRAN, E. H</creatorcontrib><creatorcontrib>ALLSOP, D</creatorcontrib><creatorcontrib>SMITH, L</creatorcontrib><creatorcontrib>GODFREY, F</creatorcontrib><creatorcontrib>MANSFIELD, F</creatorcontrib><creatorcontrib>WADSWORTH, H</creatorcontrib><creatorcontrib>KING, R</creatorcontrib><creatorcontrib>MCLAUGHLIN, M</creatorcontrib><creatorcontrib>COOPER, D. G</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of neurochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>CHRISTIE, G</au><au>MARKWELL, R. E</au><au>WARD, R. V</au><au>HOWLETT, D. R</au><au>HARTMANN, T</au><au>LICHTENTHALER, S. F</au><au>BEYREUTHER, K</au><au>UNDERWOOD, J</au><au>GRIBBLE, S. K</au><au>CAPPAI, R</au><au>MASTERS, C. L</au><au>TAMAOKA, A</au><au>GRAY, C. W</au><au>GARDNER, R. L</au><au>RIVETT, A. J</au><au>KARRAN, E. H</au><au>ALLSOP, D</au><au>SMITH, L</au><au>GODFREY, F</au><au>MANSFIELD, F</au><au>WADSWORTH, H</au><au>KING, R</au><au>MCLAUGHLIN, M</au><au>COOPER, D. G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Alzheimer's disease : Correlation of the suppression of β-amyloid Peptide secretion from cultured cells with inhibition of the chymotrypsin-like activity of the proteasome</atitle><jtitle>Journal of neurochemistry</jtitle><addtitle>J Neurochem</addtitle><date>1999-07-01</date><risdate>1999</risdate><volume>73</volume><issue>1</issue><spage>195</spage><epage>204</epage><pages>195-204</pages><issn>0022-3042</issn><eissn>1471-4159</eissn><coden>JONRA9</coden><abstract>Peptide aldehyde inhibitors of the chymotrypsin-like activity of the proteasome (CLIP) such as N-acetyl-Leu-Leu-Nle-H (or ALLN) have been shown previously to inhibit the secretion of beta-amyloid peptide (A beta) from cells. To evaluate more fully the role of the proteasome in this process, we have tested the effects on A beta formation of a much wider range of peptide-based inhibitors of CLIP than published previously. The inhibitors tested included several peptide boronates, some of which proved to be the most potent peptide-based inhibitors of beta-amyloid production reported so far. We found that the ability of the peptide aldehyde and boronate inhibitors to suppress A beta formation from cells correlated extremely well with their potency as CLIP inhibitors. Thus, we conclude that the proteasome may be involved either directly or indirectly in A beta formation.</abstract><cop>Oxford</cop><pub>Blackwell</pub><pmid>10386971</pmid><doi>10.1046/j.1471-4159.1999.0730195.x</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-3042
ispartof Journal of neurochemistry, 1999-07, Vol.73 (1), p.195-204
issn 0022-3042
1471-4159
language eng
recordid cdi_proquest_miscellaneous_69853980
source Wiley Free Content; MEDLINE; IngentaConnect Free/Open Access Journals; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Free Full-Text Journals in Chemistry
subjects Aldehydes - pharmacology
Alzheimer Disease - metabolism
Amyloid beta-Peptides - analysis
Amyloid beta-Peptides - metabolism
Amyloid beta-Protein Precursor - genetics
Biological and medical sciences
Boronic Acids - pharmacology
Cell Line
Chymotrypsin - antagonists & inhibitors
Chymotrypsin - metabolism
Cysteine Endopeptidases - metabolism
Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
Medical sciences
Multienzyme Complexes - metabolism
Neurology
Peptide Fragments - analysis
Peptide Fragments - metabolism
Proteasome Endopeptidase Complex
proteasomes
Transfection
title Alzheimer's disease : Correlation of the suppression of β-amyloid Peptide secretion from cultured cells with inhibition of the chymotrypsin-like activity of the proteasome
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T16%3A50%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Alzheimer's%20disease%20:%20Correlation%20of%20the%20suppression%20of%20%CE%B2-amyloid%20Peptide%20secretion%20from%20cultured%20cells%20with%20inhibition%20of%20the%20chymotrypsin-like%20activity%20of%20the%20proteasome&rft.jtitle=Journal%20of%20neurochemistry&rft.au=CHRISTIE,%20G&rft.date=1999-07-01&rft.volume=73&rft.issue=1&rft.spage=195&rft.epage=204&rft.pages=195-204&rft.issn=0022-3042&rft.eissn=1471-4159&rft.coden=JONRA9&rft_id=info:doi/10.1046/j.1471-4159.1999.0730195.x&rft_dat=%3Cproquest_cross%3E69853980%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17401801&rft_id=info:pmid/10386971&rfr_iscdi=true